Levodopa-Carbidopa Intestinal Gel Infusion Therapy Discontinuation: A Ten-Year Retrospective Analysis of 204 Treated Patients

BACKGROUND: Parkinson’s disease (PD) is the second most common progressive neurodegenerative disease. In the advanced stages, the continuous delivery of levodopa (LD) as levodopa-carbidopa intestinal gel (LCIG) has demonstrated significant improvement of motor and nonmotor complications and improvem...

Descripción completa

Detalles Bibliográficos
Autores principales: Constantin, Viorelia Adelina, Szász, József Attila, Orbán-Kis, Károly, Rosca, Elena Cecilia, Popovici, Maria, Cornea, Amalia, Bancu, Ligia Ariana, Ciorba, Marius, Mihály, István, Nagy, Előd, Szatmári, Szabolcs, Simu, Mihaela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395851/
https://www.ncbi.nlm.nih.gov/pubmed/32801718
http://dx.doi.org/10.2147/NDT.S256988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395851/
https://www.ncbi.nlm.nih.gov/pubmed/32801718
http://dx.doi.org/10.2147/NDT.S256988

Ejemplares similares